| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.088 | 0.004 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.004 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.2 | 0.006 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 0.007 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.095 | 0.007 |